manilatimes19m
Inhibikase Announces Expansion of Senior Leadership Team
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase” or "Company”), today announced the appointment of two pharma ...
manilatimes20m
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
Data confirms Versamune ® HPV has potential as a broadly effective treatment of HPV16-associated cancers - Initiation of Phase 3 trial in HPV16-positive HNSCC planned for Q1 2025 ...
Lexaria Bioscience Corp.: Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm
Phase 1b Study receives lead clinical site approval KELOWNA, BC / ACCESS Newswire / February 24, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria") ...
BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
ORLADEYO net revenue of $124.2 million for Q4 2024 (+36.6 percent y-o-y) and $437.7 million for FY 2024 (+34.3 percent y-o-y)——FY 2025 ORLADEYO ...
HotCopper.com on MSN7h
Actinogen reports busy 6 months as development of Xanamem molecule ramps up
Actinogen Medical Ltd (ASX:ACW) said its net loss after tax for the six months to December 2024 decreased by 29% to ...
University of Hawaii Cancer Center and Queen’s to collaborate on oncology clinic
COURTESY UH CANCER CENTER The Queen’s Health Systems and University of Hawaii Cancer Center will develop an oncology clinic at the UH John A. Burns School of Medicine in Kakaako. 1 /3 COURTESY UH ...